The BA.2 variant: What you need to know about the strain known as ‘stealth omicron’ in Arizona / Arizona Republic
BA.2 is not yet causing a rise in cases in Arizona like it is in other parts of the world, but early data suggests that BA.2’s unique characteristics give it a clear advantage over BA.1 with many suspecting increased transmissibility having something to do with it.
Experts ‘cautiously optimistic’ as COVID-19 conditions improve in Arizona / KJZZ
Arizona’s COVID-19 outbreak continues to show signs of dramatic improvement with the lowest average of daily cases since last July. Read more: After nearly 2 million COVID-19 cases in Arizona, officials are ‘cautiously optimistic’
Underrepresented Arizonans taking part in medical studies to improve medical care for all communities / Fox 10
The nationwide “All of Us” research program is signing up people to help in finding new ways to medically treat people, not only based on their conditions, but also on their genetic backgrounds and communities.
UA researchers’ startup uses artificial intelligence to detect the ‘fingerprints of disease’ / Inside Tucson Business
MetFora, a startup company co-founded by two University of Arizona researchers with help from Tech Launch Arizona, aims to detect metabolic changes with machine learning to hopefully catch diseases sooner and expedite the healing process.
Time to pick a champion: AZ Inno Madness field is down to two / Phoenix Business Journal (AZ Inno)
After three weeks of voting, the inaugural AZ Inno Madness startup competition has reached its championship round, with Phoenix startups Humabiologics and qBotica facing off for the title.
2 years of COVID-19: Pandemic exposed Arizona public health problems / Arizona Republic
The last two years of the COVID-19 pandemic in Arizona have exposed health problems that providers in the state have long known and highlighted a need to tailor messaging to marginalized communities.
Upcoming Events
March 25: Arizona BioPreneur Conference
April 4-6: Tucson Symposium 2022
April 19: AZBioPEERS: How to access non-dilutive capital for small businesses